Nerve health, once a highly specialized medical category, has now entered mainstream conversation
NHS access to semaglutide for weight management (Wegovy) is restricted to specialist services for patients with BMI 35 kg/m (or 32.5 kg/m for certain ethnic backgrounds) plus weight-related comorbidities
Your gastric emptying rate slows significantly, meaning beverages that are high in sugar, carbonation, or caffeine can irritate an already-sensitive digestive tract
Research indicates that Tirzepatide results in more significant weight loss compared to Semaglutide, with some patients seeing up to 15.3% of their body weight reduced after a year
If you are overweight, you must also have at least one weight-related health condition in order to qualify for Wegovy
Imatinib mesylate (Gleevec